日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Aerobic Exercise Training and VO(2max): A Scoping Review of Study Populations and Protocols

有氧运动训练与最大摄氧量：研究人群和方案的范围综述

期刊:Journal of Functional Morphology and Kinesiology
影响因子:2.5
doi:10.3390/jfmk11010070
Wu, Zeyu; Preobrazenski, Nicholas; Renwick, John R M; Khansari, Ava; LeBouedec, Matisse A; Nuttall, Jared M G; Mudwi, Ahmed; Ross, Brendan; Simpson-Stairs, Nia; Beaupre, Lucas P R; Swinton, Paul A; Gurd, Brendon J
发表日期：2026
文献求助 收藏

Living with chronic cough: experiences, burden and management in interstitial lung disease - a mixed methods study

慢性咳嗽患者的生活：间质性肺病患者的经历、负担和管理——一项混合方法研究

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00641-2024
Quach, Shirley; Newman, Anatasia; LeBouedec, Matisse; Mancopes, Renata; Hatzoglou, Diana; Raghavan, Natya; Brooks, Dina; Oliveira, Ana
特发性肺纤维化
发表日期：2025
文献求助 收藏

Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

对肿瘤浸润淋巴细胞的分析揭示了乳腺导管原位癌的两个新的、生物学特性不同的亚组。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-018-4013-6
Beguinot, Marie; Dauplat, Marie-Melanie; Kwiatkowski, Fabrice; Lebouedec, Guillaume; Tixier, Lucie; Pomel, Christophe; Penault-Llorca, Frederique; Radosevic-Robin, Nina
细胞生物学
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Is it important to adapt neoadjuvant chemotherapy to the visible clinical response? An open randomized phase II study comparing response-guided and standard treatments in HER2-negative operable breast cancer

根据可见的临床反应调整新辅助化疗方案是否重要？一项开放标签的随机II期研究比较了HER2阴性可手术乳腺癌患者的反应指导治疗和标准治疗方案。

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2014-0400
Wang-Lopez, Qian; Mouret-Reynier, Marie-Ange; Savoye, Aude-Marie; Abrial, Catherine; Kwiatkowski, Fabrice; Garbar, Christian; DuBray-Longeras, Pascale; Eymard, Jean-Christophe; Lebouedec, Guillaume; Vanpraagh, Isabelle; Penault-Llorca, Frederique; Chollet, Philippe; Cure, Hervé
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2015
文献求助 收藏